Poliovirus ELISA kits employ the enzyme-linked immunosorbent assay (ELISA) technique to detect and quantify antibodies—usually IgG or IgM—against poliovirus antigens in human serum or plasma samples. Typically, microplate wells are coated with poliovirus-specific antigens. Patient samples containing poliovirus antibodies bind to these immobilized antigens during incubation. Following washing steps, enzyme-conjugated secondary antibodies specific to human immunoglobulins are added, which bind to the captured antibodies. The addition of a chromogenic substrate, such as tetramethylbenzidine (TMB), results in a color change proportional to the antibody concentration, measured spectrophotometrically at 450 nm.
Applications
- Detection and quantification of poliovirus IgG antibodies for assessment of immunity due to vaccination or past infection.
- Identification of recent infection through IgM antibody detection.
- Epidemiological surveillance during poliovirus eradication programs.
- Research into immune response to poliovirus and vaccine efficacy evaluation.
In conclusion, the Poliovirus ELISA kit is a robust, sensitive, and specific immunoassay essential for clinical diagnosis, immunity assessment, and epidemiological monitoring of poliovirus infections. Its quantitative nature facilitates evaluation of vaccine-induced immunity and supports global poliovirus eradication efforts.
